Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Malika L. Siker MD

Malika L. Siker MD profile photo picture

Associate Dean, Associate Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology
Program: Clinical

Member of the Center for Disease Prevention Research (CDPR)
Member of the Kern Institute

View Curriculum Vitae

Publications (40)

  • Demographics of ASTRO Student Members and Potential Implications for Future U.S. Radiation Oncology Workforce Diversity (Mattes MD, Deville C, Vega RBM, Fung CY, Suneja G, Shumway JW, Chowdhary M, Shah C, Bates JE, Mohindra P, Siker ML, Winkfield KM, Vapiwala N, Royce TJ) Advances in Radiation Oncology 1 March 2022;7(2) SCOPUS ID: 2-s2.0-85121184807 03/01/2022       1 Citation
  • Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer (Beltrán Ponce SE, Erickson BA, Hall WA, Bedi M, Martens MJ, Siker M, Thomas J, George B, Ludwig K, Peterson C, Ridolfi T, Longo JM) Journal of Gastrointestinal Oncology February 2022;13(1):185-196 SCOPUS ID: 2-s2.0-85125562951 02/01/2022    
  • Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy. (Bero EH, Rein LE, Banerjee A, Straza MW, Lawton CAF, Schultz CJ, Erickson BA, Siker ML, Hall WA) Pract Radiat Oncol 2021 Nov-Dec;11(6):453-459 PMID: 34742459 SCOPUS ID: 2-s2.0-85118502646 11/08/2021    
  • The Impact of the ASTRO Aspiring Scientists and Physicians Program (ASPP) on Diverse STEM Students' Perception of Radiation Oncology (Williams VM, Vega RM, LeCompte MC, Sanders T, Diaz R, Suneja G, Siker ML, Deville C, Woodhouse KD) International journal of radiation oncology, biology, physics 1 November 2021;111(3):S30 PMID: 34700530 SCOPUS ID: 2-s2.0-85120930834 11/01/2021    
  • Diversity, Equity, and Inclusion Perspectives Among Radiation Oncology Program Directors: A Knowledge, Attitudes, and Practices Survey (Williams VM, Franco II, Tye KE, Jagsi R, Sim AJ, Rivera A, Oladeru OT, Deville C, Siker ML, Suneja G, Halasz LM, Balogun OD, Agarwal A, Vapiwala N, Elmore SNC) International journal of radiation oncology, biology, physics 1 November 2021;111(3):e340 PMID: 34701222 SCOPUS ID: 2-s2.0-85120926990 11/01/2021    
  • Assessment of Differences in Academic Rank and Salary by Gender and Race Among United States Academic Radiation Oncologists (Raldow A, Siker ML, Bonner JA, Chen Y, Liu FF, Metz JM, Movsas B, Potters L, Schultz CJ, Sanders T, Wang X, Steinberg ML, Jagsi R) International journal of radiation oncology, biology, physics 1 November 2021;111(3):e338-e339 PMID: 34701216 SCOPUS ID: 2-s2.0-85120926127 11/01/2021    
  • Overcoming Barriers to Radiation Oncology Access in Low-Resource Settings in the United States (Mattes MD, Suneja G, Haffty BG, Takita C, Katz MS, Ohri N, Deville C, Siker ML, Park HS) Advances in Radiation Oncology 1 November 2021;6(6) SCOPUS ID: 2-s2.0-85122814602 11/01/2021       1 Citation
  • Enhancing Patient-Physician Experience in the Digital Era: A Review of Mobile Health Applications for Oncology Patients. (Cooper B, Bedi M, Bovi JA, Currey AD, Erickson BA, Gore EM, Hall WA, Lawton CAF, Schultz CJ, Siker ML, Saeed H) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e105-e106 PMID: 34700689 SCOPUS ID: 2-s2.0-85120927766 10/28/2021    
  • Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. (Conger R, Mora J, Straza MW Jr, Erickson BA, Lawton CAF, Schultz CJ, Currey AD, Bedi M, Saeed H, Tsai S, Siker ML, Hall WA) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e105 PMID: 34700688 SCOPUS ID: 2-s2.0-85120931396 10/28/2021    
  • Mitigating Implicit Bias in Radiation Oncology (Diaz DA, Suneja G, Jagsi R, Barry P, Thomas CR, Deville C, Winkfield K, Siker M, Bott-Kothari T) Advances in Radiation Oncology 1 September 2021;6(5) SCOPUS ID: 2-s2.0-85111316849 09/01/2021       1 Citation
  • Standardizing Professional Title Use at American Society for Radiation Oncology Annual Meetings (Siker ML, Ng AK) International Journal of Radiation Oncology Biology Physics 1 June 2021;110(2):312-314 SCOPUS ID: 2-s2.0-85105255425 06/01/2021       1 Citation
  • Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF) Pract Radiat Oncol 2021 Nov-Dec;11(6):527-533 PMID: 33848618 PMCID: PMC8638529 SCOPUS ID: 2-s2.0-85107984420 04/14/2021    
  • Improving the Clinical Treatment of Vulnerable Populations in Radiation Oncology (McClelland S, Petereit DG, Zeitlin R, Takita C, Suneja G, Miller RC, Deville C, Siker ML) Advances in Radiation Oncology 1 November 2020;5(6):1093-1098 SCOPUS ID: 2-s2.0-85090061444 11/01/2020    
  • Lessons From COVID-19: Addressing Health Equity in Cancer Care (Siker ML, Deville C, Suneja G, Winkfield K) International Journal of Radiation Oncology Biology Physics 1 October 2020;108(2):475-478 SCOPUS ID: 2-s2.0-85090023271 10/01/2020       4 Citations
  • Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce: A Summary of the 2019 ASTRO/NCI Diversity Symposium Session at the ASTRO Annual Meeting (Suneja G, Mattes MD, Mailhot Vega RB, Escorcia FE, Lawton C, Greenberger J, Kesarwala AH, Spektor A, Vikram B, Deville C, Siker M) Advances in Radiation Oncology 1 September 2020;5(5):798-803 SCOPUS ID: 2-s2.0-85087028121 09/01/2020       2 Citations
  • 'Knowing What's Best': Community Partnerships Against COVID-19. (Abenoza N, Hernandez C, Martinez E, Mora J, Siker M) WMJ 2020 06;119(2):76 PMID: 32659055 SCOPUS ID: 2-s2.0-85088026325 07/14/2020       1 Citation
  • Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes. (Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ) Int J Radiat Oncol Biol Phys 2020 11 15;108(4):979-986 PMID: 32599030 PMCID: PMC8655709 SCOPUS ID: 2-s2.0-85089292279 07/01/2020       6 Citations
  • Halfway Toward Half Full. (Siker M, Kavanagh BD) Int J Radiat Oncol Biol Phys 2019 08 01;104(5):997-998 PMID: 31327431 SCOPUS ID: 2-s2.0-85068834659 07/23/2019       1 Citation
  • Erratum: Holliday EB, Siker M, Chapman CH, Jagsi R, Bitterman DS, Ahmed AA, Winkfield K, Kelly M, Tarbell NJ, Deville Jr C: Achieving Gender Equity in the Radiation Oncology Physician Workforce (Advances in Radiation Oncology 2018;3:478-483). Adv Radiat Oncol 2019 Jan-Mar;4(1):210 PMID: 30706030 PMCID: PMC6349640 SCOPUS ID: 2-s2.0-85059887052 02/02/2019    
  • Achieving gender equity in the radiation oncology physician workforce. (Holliday EB, Siker M, Chapman CH, Jagsi R, Bitterman DS, Ahmed AA, Winkfield K, Kelly M, Tarbell NJ, Deville C Jr) Adv Radiat Oncol 2018 Oct-Dec;3(4):478-483 PMID: 30370345 PMCID: PMC6200884 SCOPUS ID: 2-s2.0-85055180461 10/30/2018       38 Citations
  • Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. (Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA) Neurosurgery 2018 05 01;82(5):595-603 PMID: 29669114 SCOPUS ID: 2-s2.0-85068839760 04/19/2018       7 Citations
  • Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT Histologies. (Dhakal B, Fenske TS, Ramalingam S, Shuff J, Epperla N, Hosking P, Rein L, Banerjee A, Hari P, D'Souza A, Shah N, Siker M, Griepentrog GJ, Harris GJ, Wells TS, Erickson BA, Hamadani M) Clin Lymphoma Myeloma Leuk 2017 05;17(5):305-311.e2 PMID: 28284742 SCOPUS ID: 2-s2.0-85015693044 03/13/2017       6 Citations
  • Pulsed Reduced Dose Rate Reirradiation (PRDR) Using Modulated Arc (mARC) Intensity Modulated Radiation Therapy for Recurrent Gliomas: Initial Clinical Outcomes of a Novel Technique. (Siker ML, Firat S, Prah D, Schultz CJ, Dayal A, Masterson C, Connelly JM, Mueller WM, Bovi JA) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E125-E126 PMID: 27673841 09/28/2016    
  • Clinical Significance of Updated MRI Simulation Versus Immediate Postoperative MRI for Radiation Treatment Planning in Patients With Glioblastoma: Changes in FLAIR Signal. (Dayal A, Siker ML, Firat S, Bovi JA, Schultz CJ, Mueller WM, Connelly JM, Rand SD) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E103 PMID: 27673785 09/28/2016    
  • Advances in the treatment of brain metastases (Siker ML, Mehta MP) Lung Cancer: Translational and Emerging Therapies 19 April 2016:207-230 SCOPUS ID: 2-s2.0-85127944695 04/19/2016    
  • Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. (Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS) J Neurooncol 2015 May;123(1):179-88 PMID: 25894597 SCOPUS ID: 2-s2.0-84929836750 04/22/2015       18 Citations
  • Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma. (Elson A, Bovi J, Siker M, Schultz C, Paulson E) J Neurooncol 2015 May;122(3):549-58 PMID: 25700835 SCOPUS ID: 2-s2.0-84939984579 02/24/2015       19 Citations
  • Comparing the quality of passively-scattered proton and photon tomotherapy plans for brain and head and neck disease sites. (Kainz K, Firat S, Wilson JF, Schultz C, Siker M, Wang A, Olson D, Li XA) Phys Med Biol 2015 Mar 21;60(6):2167-77 PMID: 25683607 SCOPUS ID: 2-s2.0-84924658067 02/17/2015       1 Citation
  • Spinal Cord Tumors (Siker ML, Bovi J, Alexander B) Clinical Radiation Oncology 1 January 2015:521-540.e5 SCOPUS ID: 2-s2.0-85072318941 01/01/2015       2 Citations
  • Spinal Cord Tumors (Stieber VW, Siker ML) Clinical Radiation Oncology: Third Edition 2012:511-528 SCOPUS ID: 2-s2.0-84967106647 01/01/2012    
  • Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study. (Siker ML, Firat SY, Mueller W, Krouwer H, Schultz CJ) Int J Radiat Oncol Biol Phys 2012 Feb 01;82(2):765-72 PMID: 21236600 SCOPUS ID: 2-s2.0-84855841206 01/18/2011       6 Citations
  • Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison. (Siker ML, Wang M, Porter K, Nelson DF, Curran WJ, Michalski JM, Souhami L, Chakravarti A, Yung WK, Delrowe J, Coughlin CT, Mehta MP) J Neurooncol 2011 Aug;104(1):351-6 PMID: 21221714 SCOPUS ID: 2-s2.0-80052772289 01/12/2011       27 Citations
  • Role of radiation therapy in cutaneous melanoma. (Shuff JH, Siker ML, Daly MD, Schultz CJ) Clin Plast Surg 2010 Jan;37(1):147-60 PMID: 19914465 SCOPUS ID: 2-s2.0-70449432830 11/17/2009       7 Citations
  • SU‐FF‐J‐35: Severe Inter‐Fractional Anatomic Changes and Their Dosimetric Impact in Abdominal Irradiation, An Indication for Adaptive Re‐Planning (qi X, Wang K, Siker M, Firat S, Erickson B, li X) Medical Physics June 2009;36(6):2483 SCOPUS ID: 2-s2.0-85024822248 01/01/2009    
  • Enhanced methods for assessment of the trace element composition of Iron Age bone. (Shafer MM, Siker M, Overdier JT, Ramsl PC, Teschler-Nicola M, Farrell PM) Sci Total Environ 2008 Aug 15;401(1-3):144-61 PMID: 18486196 SCOPUS ID: 2-s2.0-44749092857 05/20/2008       31 Citations
  • Radiation for brain metastases. (Siker ML, Mehta MP) Cancer Treat Res 2007;136:91-115 PMID: 18078267 SCOPUS ID: 2-s2.0-38449119192 12/15/2007       1 Citation
  • Resection versus radiosurgery for patients with brain metastases. (Siker ML, Mehta MP) Future Oncol 2007 Feb;3(1):95-102 PMID: 17280506 SCOPUS ID: 2-s2.0-33847072268 02/07/2007       14 Citations
  • Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? (Siker ML, Chakravarti A, Mehta MP) Crit Rev Oncol Hematol 2006 Nov;60(2):99-111 PMID: 17027279 SCOPUS ID: 2-s2.0-33750339323 10/10/2006       31 Citations
  • Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect? (Siker ML, Tomé WA, Mehta MP) Int J Radiat Oncol Biol Phys 2006 Sep 01;66(1):135-41 PMID: 16839704 SCOPUS ID: 2-s2.0-33746814036 07/15/2006       97 Citations
  • Stereotactic radiosurgery for four or more intracranial metastases: Implications and future directions (Siker ML, Mehta MP) American Journal of Oncology Review May 2006;5(5):316-318 SCOPUS ID: 2-s2.0-33745875041 05/01/2006       1 Citation
    • Last update: 06/21/2022